Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension (2008)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.clinbiochem.2008.04.015
- Subjects: HIPERTENSÃO NA GRAVIDEZ; PRÉ-ECLÂMPSIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Biochemistry
- ISSN: 0009-9120
- Volume/Número/Paginação/Ano: v. 41, n. 10-11, p. 875-880, 2008
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PALEI, Ana C. T. et al. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, v. 41, n. 10-11, p. 875-880, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2008.04.015. Acesso em: 24 jan. 2026. -
APA
Palei, A. C. T., Sandrim, V. C., Cavalli, R. C., & Tanus-Santos, J. E. (2008). Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, 41( 10-11), 875-880. doi:10.1016/j.clinbiochem.2008.04.015 -
NLM
Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015 -
Vancouver
Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015 - Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study
- Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices
- Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension
- Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
Informações sobre o DOI: 10.1016/j.clinbiochem.2008.04.015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
